Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Warnings In 2019, AERs In 2009: Touchstones Toward Homeopathic Guidance

Oct 24 2019

• By Malcolm Spicer

Guidance word in red keyboard buttons

Related Content

What Does FDA Deem A "Serious Adverse Event"? Matrixx Learns The Hard Way

Jun 29 2009

Supreme Court's Matrixx Decision Expands Firms' Disclosure Burden

Mar 28 2011

Supreme Court's Matrixx Decision Expands Firms' Disclosure Burden

Mar 28 2011

Remediations For Three Homeopathic Firms, End Of Production For Another

May 14 2019

Additional Topics

United States OTC Drugs Drug Approval Standards FDA Advertising, Marketing & Sales Business Strategies Commercial Compliance Enforcement Manufacturing Policy Regulation Safety Consumer

More from Regulation

More from Policy & Regulation

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.